Cargando…
COVID-19 intranasal vaccines: current progress, advantages, prospects, and challenges
Multiple vaccines have recently been developed, and almost all the countries are presently vaccinating their population to tackle the COVID-19 pandemic. Most of the COVID-19 vaccines in use are administered via intramuscular (IM) injection, eliciting protective humor and cellular immunity. COVID-19...
Autores principales: | Dhama, Kuldeep, Dhawan, Manish, Tiwari, Ruchi, Emran, Talha Bin, Mitra, Saikat, Rabaan, Ali A., Alhumaid, Saad, Alawi, Zainab Al, Al Mutair, Abbas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8935456/ https://www.ncbi.nlm.nih.gov/pubmed/35258416 http://dx.doi.org/10.1080/21645515.2022.2045853 |
Ejemplares similares
-
Strategies to tackle SARS-CoV-2 Mu, a newly classified variant of interest likely to resist currently available COVID-19 vaccines
por: Hossain, Md. Jamal, et al.
Publicado: (2022) -
Regulatory T cells (Tregs) and their therapeutic potential against autoimmune disorders – Advances and challenges
por: Goswami, Tapas Kumar, et al.
Publicado: (2022) -
Prophylactic and therapeutic insights into trained immunity: A renewed concept of innate immune memory
por: Bindu, Suresh, et al.
Publicado: (2022) -
Viral Dynamics and Real-Time RT-PCR Ct Values Correlation with Disease Severity in COVID-19
por: Rabaan, Ali A., et al.
Publicado: (2021) -
Oral and intranasal vaccines against SARS‐CoV‐2: Current progress, prospects, advantages, and challenges
por: Kar, Sanchita, et al.
Publicado: (2022)